Description: ProstaLund AB (publ), a medical technology company, develops, manufactures, and sells urological devices and treatments in Sweden and internationally. It offers CoreTherm, a heat treatment for benign prostate enlargement; CoreFlow soft stent; Oruflow, a urine flow meter; Dosi-Fuser, a disposable continuous infusion system; and Dosi-Flow, a gravitation unit with a flow regulator for dosing of medicines. The company also provides Schelin Catheter, an injection tool that allows the urologists to administer drugs into the prostate in a sterile way through the urethra. Its products are used in hospitals and clinics. The company was founded in 1991 and is based in Lund, Sweden. ProstaLund AB (publ) is a subsidiary of Farstorps Gard Forvaltnings AB.
Home Page: prostalund.se
Scheelevägen 19
Lund,
223 63
Sweden
Phone:
46 46 12 09 08
Officers
| Name | Title |
|---|---|
| Mr. Anders Kristensson | Chief Executive Officer |
| Mr. Niclas Nystroom | Chief Financial Officer |
| Mr. Johan Laven | Director of Sales & Marketing |
Exchange: ST
Country: SE : Sweden
Currency: Swedish krone (kr)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Health Care Equipment & Services |
| GIC Industry: | Health Care Providers & Services |
| GIC Sub-Industry: | Health Care Services |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0.5099 |
| Price-to-Sales TTM: | 1.8073 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 9 |